Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial

AIM: To examine whether the velocity of saccadic eye movements in internuclear ophthalmoparesis (INO) improves with fampridine treatment in patients with multiple sclerosis (MS). METHODS: Randomized, double‐blind, placebo‐controlled, cross‐over trial with fampridine in patients with MS and INO. Hori...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:CNS Neurosci Ther
Auteurs principaux: Kanhai, Kawita M. S., Nij Bijvank, Jenny A., Wagenaar, Yorick L., Klaassen, Erica S., Lim, KyoungSoo, Bergheanu, Sandrin C., Petzold, Axel, Verma, Ajay, Hesterman, Jacob, Wattjes, Mike P., Uitdehaag, Bernard M. J., van Rijn, Laurentius J., Groeneveld, Geert Jan
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6515699/
https://ncbi.nlm.nih.gov/pubmed/30756475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13096
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires